PortfoliosLab logoPortfoliosLab logo
FLGT vs. SMG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FLGT vs. SMG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FLGT achieves a -37.00% return, which is significantly lower than SMG's 14.91% return.


FLGT

1D
-18.11%
1M
-20.62%
6M
-36.83%
YTD
-37.00%
1Y
-10.69%
3Y*
-24.74%
5Y*
-29.08%
10Y*
ALL TIME*
6.14%

SMG

1D
-3.85%
1M
-4.60%
6M
4.41%
YTD
14.91%
1Y
10.94%
3Y*
1.54%
5Y*
-14.82%
10Y*
2.12%
ALL TIME*
7.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$6.50M$5.58M$7.39M
$71.67M$69.95M$61.63M

FLGT vs. SMG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FLGT
Fulgent Genetics, Inc.
-37.00%42.23%-36.11%-2.92%-70.39%93.07%303.88%306.94%-27.63%-62.14%
SMG
The Scotts Miracle-Gro Company
14.91%-8.01%8.28%36.92%-68.81%-18.03%96.18%77.05%-41.00%14.46%

Correlation

The correlation between FLGT and SMG is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.25

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.31

Correlation (All Time)
Calculated using the full available price history since Sep 29, 2016

0.21

The correlation between FLGT and SMG shifts across timeframes, from 0.15 (1 year) to 0.31 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FLGT:

$470.03M

SMG:

$3.82B

EPS

FLGT:

-$2.80

SMG:

$1.12

PS Ratio

FLGT:

1.54

SMG:

1.14

Total Revenue (TTM)

FLGT:

$323.93M

SMG:

$3.37B

Gross Profit (TTM)

FLGT:

$115.26M

SMG:

$1.09B

EBITDA (TTM)

FLGT:

-$72.79M

SMG:

$434.60M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FLGT vs. SMG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FLGT
FLGT Risk / Return Rank: 4343
Overall Rank
FLGT Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
FLGT Sortino Ratio Rank: 4242
Sortino Ratio Rank
FLGT Omega Ratio Rank: 4747
Omega Ratio Rank
FLGT Calmar Ratio Rank: 4242
Calmar Ratio Rank
FLGT Martin Ratio Rank: 4242
Martin Ratio Rank

SMG
SMG Risk / Return Rank: 5353
Overall Rank
SMG Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
SMG Sortino Ratio Rank: 4949
Sortino Ratio Rank
SMG Omega Ratio Rank: 4848
Omega Ratio Rank
SMG Calmar Ratio Rank: 5757
Calmar Ratio Rank
SMG Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FLGT vs. SMG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FLGTSMGDifference
Sharpe ratioReturn per unit of total volatility

-0.32

Sortino ratioReturn per unit of downside risk

-0.29

Omega ratioGain probability vs. loss probability

1.07

1.08

-0.01

Calmar ratioReturn relative to maximum drawdown

-0.07

0.48

-0.54

Martin ratioReturn relative to average drawdown

-0.12

1.00

-1.13

FLGT vs. SMG - Sharpe Ratio Comparison

The current FLGT Sharpe Ratio is -0.06, which is lower than the SMG Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of FLGT and SMG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FLGT vs. SMG - Drawdown Comparison

The maximum FLGT drawdown since its inception was -92.50%, which is greater than SMG's maximum drawdown of -83.55%. Use the drawdown chart below to compare losses from any high point for FLGT and SMG.


Loading charts...

Drawdown Indicators


FLGTSMGDifference

Max Drawdown

Largest peak-to-trough decline

-92.50%

-83.55%

-8.95%

Max Drawdown (1Y)

Largest decline over 1 year

-55.30%

-20.12%

-35.18%

Max Drawdown (3Y)

Largest decline over 3 years

-64.54%

-47.42%

-17.12%

Max Drawdown (5Y)

Largest decline over 5 years

-87.56%

-76.67%

-10.89%

Max Drawdown (10Y)

Largest decline over 10 years

-83.55%

Current Drawdown

Current decline from peak

-91.00%

-68.50%

-22.50%

Average Drawdown

Average peak-to-trough decline

-61.99%

-22.18%

-39.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.18%

9.53%

+20.65%

Volatility

FLGT vs. SMG - Volatility Comparison

Fulgent Genetics, Inc. (FLGT) has a higher volatility of 21.41% compared to The Scotts Miracle-Gro Company (SMG) at 14.53%. This indicates that FLGT's price experiences larger fluctuations and is considered to be riskier than SMG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FLGTSMGDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.41%

14.53%

+6.88%

Volatility (6M)

Calculated over the trailing 6-month period

60.11%

30.08%

+30.03%

Volatility (1Y)

Calculated over the trailing 1-year period

60.38%

36.38%

+24.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.92%

46.85%

+4.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.46%

40.72%

+34.74%

Dividends

FLGT vs. SMG - Dividend Comparison

FLGT has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.02%.


PositionTTM20252024202320222021202020192018201720162015
FLGT
Fulgent Genetics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMG
The Scotts Miracle-Gro Company
4.02%4.52%3.98%4.14%5.43%1.59%3.72%2.13%3.51%1.93%2.03%2.85%

Financials

FLGT vs. SMG - Financials Comparison

This section allows you to compare key financial metrics between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

FLGT vs. SMG - Profitability Comparison

The chart below illustrates the profitability comparison between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported a gross profit of 25.68M and revenue of 85.39M. Therefore, the gross margin over that period was 30.1%.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported a gross profit of 365.90M and revenue of 1.17B. Therefore, the gross margin over that period was 31.2%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported an operating income of -29.72M and revenue of 85.39M, resulting in an operating margin of -34.8%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported an operating income of 169.60M and revenue of 1.17B, resulting in an operating margin of 14.5%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported a net income of -29.53M and revenue of 85.39M, resulting in a net margin of -34.6%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported a net income of 103.60M and revenue of 1.17B, resulting in a net margin of 8.8%.


Frequently Asked Questions


FLGT and SMG have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FLGT has higher volatility (21.41%) compared to SMG (14.53%). In terms of maximum drawdown, FLGT dropped -92.50% vs SMG's -83.55%.

SMG currently has the higher Sharpe Ratio (0.26 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FLGT and SMG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer